A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas.
J Oncol
; 2022: 6345160, 2022.
Article
in En
| MEDLINE
| ID: mdl-35712126
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Oncol
Year:
2022
Document type:
Article
Affiliation country: